Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: pain; Heavy periods; blood clots; Painful periods; This is a spontaneous report from a contactable consumer. This is a report received from the Regulatory Agency.The regulatory authority report number is GB-MHRA-WEBCOVID-202106051644007620-EZZ9T,Safety Report Unique Identifier GB-MHRA-ADR 25426130. A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), the first dose via an unspecified route of administration on 25May2021 (Batch/Lot Number: Et8885) as single dose for COVID-19 immunisation. Medical history included suppressed lactation from an unknown date, suspected covid-19 from an unknown date (Unsure when symptoms started/ Unsure when symptoms stopped), dysmenorrhoea from an unknown date. Patient was not enrolled in clinical trial. Patient was not pregnant. Patient was not currently breastfeeding. Concomitant medications included paracetamol (Manufacturer unknown) taken for dysmenorrhoea from 04Jun2021 to an unspecified stop date. The patient experienced pain on an unspecified date, heavy periods on 05Jun2021, painful periods on 04Jun2021. Her period had been so heavy she hadn''t been able to be away from a toilet for more than 20 minutes. Her menstrual cup was filling and overflowing within 30 minutes and she was passing golf ball sized blood clots. Last night her period was causing her far more pain than usual. Patient had not tested positive for COVID-19 since having the vaccine. The events were reported as serious due to medically significant. The patient underwent lab tests and procedures which included COVID-19 virus test: no-negative covid-19 test on an unspecified date. The outcome of the event pain was unknown, while the other events were not recovered. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166